BVS vs PNR · rev $285.3M vs P/E 18, rev $4.18B
Bioventus Inc (BVS) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
BVS currently screens at market cap $495.1M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the BVS and PNR stock pages for the full models.
Not investment advice.